Search Results
Results found for "multiplex assays"
- Sri Kosuri | Dr. GPCR Ecosystem
built numerous technologies in gene synthesis, DNA information storage, gene editing, and large-scale multiplexed assays.
- Self-Learning, Collaboration, and Delegation in Science with Dr. Badr Sokrat | Dr. GPCR Ecosystem
Badr recounted Badr's Journey, Multiplexing Assays, and Collaboration Badr shared his learning process Yamina emphasized the potential of multiplexing assays in expanding the scope of scientific exploration
- Hacking GPCRs: Tools, Tech & Drug Discovery with Tom Sakmar & Ilana Kotliar | Dr. GPCR Ecosystem
assay.” – Tom Sakmar After exploring several screening techniques, the lab adopted the Luminex bead-based assay , which allowed simultaneous detection of multiple GPCR-RAMP interactions. assays. focusing on a single receptor, students now gravitate toward platforms , biosensors , and data-rich assays Keyword Cloud GPCR-RAMP interactions , multiplex assays , GPCR research community , Dr.
- What if you could map GPCR-RAMP interactions across the entire superfamily in a single experiment? That’s precisely what Dr. Kotliar from the Sakmar lab made possible! In Ep.167 of the Dr. GPCR Podcast, we chat with Drs. Tom Sakmar and Ilana Kotliar about how their lab developed: A multiplexed Luminex assay to screen hundreds of interactions at once A 220-clone DUET-tagged GPCR library, available on Addgene An online interface to search GPCR-RAMP data and antibody validations This is open-access science at its best, built for the GPCR research community. ✳️ Listen to the episode: Ep 167 with Drs. Tom Sakmar & Ilana Kotliar #GPCRresearch #DrGPCRecosystem #GPCRdrugdiscovery #GPCRtrainingprogram #GPCRpodcast | Dr. GPCR Ecosystem
Tom Sakmar and Ilana Kotliar about how their lab developed: A multiplexed Luminex assay to screen hundreds Tom Sakmar and Ilana Kotliar about how their lab developed: A multiplexed Luminex assay to screen hundreds
- Forget one receptor at a time. Go big.Ep.167 of the Dr.GPCR Podcast with Tom Sakmar & Ilana Kotliar is about scaling GPCR research with multiplexing, miniaturization, and collaboration. The tools are built. The data is free. What will you ask next? 📲 Dive in: Ep 167 with Drs. Tom Sakmar & Ilana Kotliar #GPCRtraining #GPCRresearchcommunity #DrGPCR #GPCRdata | Dr. GPCR Ecosystem
big.Ep.167 of the Dr.GPCR Podcast with Tom Sakmar & Ilana Kotliar is about scaling GPCR research with multiplexing big.Ep.167 of the Dr.GPCR Podcast with Tom Sakmar & Ilana Kotliar is about scaling GPCR research with multiplexing
- New biosensor technologies are shedding light on GPCR dynamics directly in cells, offering exciting possibilities for multiplexing and miniaturization! Curious about how these advances could impact drug discovery? Check out the latest review on GPCR biosensors. Check out the latest GPCR news in the Ecosystem today! You’ll need to register but don’t worry, it’s Free! | Dr. GPCR Ecosystem
technologies are shedding light on GPCR dynamics directly in cells, offering exciting possibilities for multiplexing technologies are shedding light on GPCR dynamics directly in cells, offering exciting possibilities for multiplexing
- Eurofins DiscoverX | Dr. GPCR | Dr. GPCR Ecosystem
DiscoverX leads GPCR research innovation with 25+ years of expertise and provides you with cell-based assay These industry-standard assays, designed for regulatory submissions, are backed by partnerships with Assay Principle of Eurofins DiscoverX Cell-based Assays Whether you are developing small-molecule or assay types and applications to meet your specific GPCR research needs. These assays use the same platform as the Eurofins DiscoverX assays and beyond.
- New strategic partnership alert! 🚀 Dr.GPCR x Celtarys are teaming up to revolutionize fluorescent ligand development for GPCR research. Get custom, fast, and functional ligands backed by real scientists solving real assay problems. 🧪 “We don’t just deliver compounds. We solve assay problems.” – Dr. Maria Majellaro, CSO, Celtarys Listen to Ep. 168 now and meet your new assay partner 😉 ✳️ https://www.ecosystem.drgpcr.com/dr-gpcr-podcast/ep-168-with-dr.-maria-majellaro-from-celtarys #GPCRdrugDiscovery #FluorescentLigands #DrGPCR #BiotechTools #AssayDevelopment | Dr. GPCR Ecosystem
Get custom, fast, and functional ligands backed by real scientists solving real assay problems. 🧪 “We We solve assay problems.” – Dr. Maria Majellaro, CSO, Celtarys Listen to Ep. 168 now and meet your new assay partner 😉 ✳️ https://www.ecosystem.drgpcr.com Get custom, fast, and functional ligands backed by real scientists solving real assay problems. 🧪 “We We solve assay problems.” – Dr.
- Did you know that certain ergot derivatives can produce wash-resistant signalling through the 5-HT2B receptor persisting for many hours without losing potency or efficacy? By using signalling assays, radioligand binding assay, and microscopy, Gaidarov et al. suggested that this phenomenon results from persistently/irreversibly internalised signalling receptor complexes. Check out the latest GPCR news in the Ecosystem today! You’ll need to register but don’t worry, it’s Free! ➡️ https://www.ecosystem.drgpcr.com/receptor-activation-and-signaling/mechanisms-of-constitutive-and-agonist-induced-5-ht2b-internalization%2C-persistent-endosomal-signaling-and-paradoxical-regulation-of-agonist-pharmacology #gpcr#drgpcr | Dr. GPCR Ecosystem
By using signalling assays, radioligand binding assay, and microscopy, Gaidarov et al. suggested that By using signalling assays, radioligand binding assay, and microscopy, Gaidarov et al. suggested that
- From Rare Earth Probes to Internalization Assays: The pHSense Story with Dr. Eric Trinquet | Dr. GPCR Ecosystem
Trinquet discusses the science and story behind pH Sense, Revvity’s innovative GPCR internalization assay product R&D. << Back to podcast list Strategic Partner(s) From Rare Earth Probes to Internalization Assays Eric Trinquet What does it take to design a breakthrough GPCR assay—from idea to industrial impact? With a career spanning two decades at the intersection of fluorescence chemistry, functional assays, What shifted the team’s strategy from traditional calcium assays to IP1 accumulation—and why it mattered
- Do you know we can discover allosteric modulators that bind to the intracellular allosteric binding site to better fine-tune the GPCRs’ activity? Check out the development of a NanoBRET assay platform to detect intracellular ligands for the chemokine receptors CCR6 and CXCR1. Check out the latest GPCR news in the Ecosystem today! You’ll need to register but don’t worry, it’s Free! | Dr. GPCR Ecosystem
Check out the development of a NanoBRET assay platform to detect intracellular ligands for the chemokine Check out the development of a NanoBRET assay platform to detect intracellular ligands for the chemokine ➡️ https://www.ecosystem.drgpcr.com/methods-and-updates-in-gpcr-research/development-of-a-nanobret-assay-platform-to-detect-intracellular-ligands-for-the-chemokine-receptors-ccr6
- Exploring the combination of molecular simulation, pharmacological assays, and NMR to reveal the molecular mechanism of biased activation at the vasopressin V2 receptor. Did you know that we work hard to bring you the most recent GPCR News, weekly? Catch up today in the Ecosystem using your free site membership! | Dr. GPCR Ecosystem
Home → Flash News → Exploring the combination of molecular simulation, pharmacological assays, and NMR , 2024 Category GPCR Weekly News Exploring the combination of molecular simulation, pharmacological assays
- A casual postdoc in Santiago. A bold yes during the pandemic. Now? A biotech startup solving GPCR challenges worldwide 🌎 Celtarys Research didn’t follow the script, and neither does their chemistry. 🎧 In this week’s episode, Dr. Maria Majellaro talks about trusting your gut, learning to lead, and building science that scales. ✳️Celtarys is ready to support your assay development. Get to know more: Celtarys Research | Dr. GPCR Ecosystem | Dr. GPCR Ecosystem #GPCRtools #GPCRtrainingProgram #DrGPCR #BiotechLeadership | Dr. GPCR Ecosystem
✳️Celtarys is ready to support your assay development. Get to know more: Celtarys Research | Dr. ✳️Celtarys is ready to support your assay development. Get to know more: Celtarys Research | Dr.
- Started in medicinal chemistry. Got hooked on ligand design. Dr. Maria Majellaro didn’t plan to run a biotech company. A thesis project, a mentor’s advice, and a leap during the pandemic changed everything. Now she’s leading Celtarys, building custom fluorescent probes, and partnering with Dr. GPCR to support assay development worldwide. Meet Celtarys and learn more about its leading work on ligand-linker-fluorophore chemistry 🚀 ✳️ Listen now: https://www.ecosystem.drgpcr.com/dr-gpcr-podcast/ep-168-with-dr.-maria-majellaro-from-celtarys #GPCRcommunity #DrGPCR #FluorescentLigands #GPCRdrugDiscovery #ScientificLeadership #BiotechInnovation | Dr. GPCR Ecosystem
GPCR to support assay development worldwide. GPCR to support assay development worldwide.
- Visualizing GPCRs in their native environment changes everything | Dr. GPCR Ecosystem
surface pools with precision Tissue-level insights reshaping metabolic disease research What’s next: multiplex
- Leadership, Impact, and GPCR Signaling with Dr. Michelle Halls | Dr. GPCR Ecosystem
Michelle Halls reveals how organized GPCR signaling drives assay innovation and new therapeutic insights This conversation is especially valuable for scientists developing functional assays, fluorescence-based What early cyclic AMP assays revealed about spatial signaling long before high-content technologies existed development and GPCR research. ⸻ Why It Might Hit Home If you’ve ever: Faced unexpected assay behavior Get behind-the-scenes conversations, advanced assay development strategies, and practical GPCR tools
- 🚨 Exciting Opportunity for Professionals in Drug Development! 🚨 Register today for a one-of-a-kind online course at Dr. GPCR University: "Development of GPCR Ligands as Therapeutic Drugs." 🗓 Dates: March 20 - April 10, 2025 ⏰ Time: Thursdays, 10:00 AM - 11:30 AM (EST) This advanced course is essential for anyone working in drug development and focuses on: The essentials of new drug development Key pharmacokinetic elements (absorption, distribution, clearance) Hepatic metabolism and the Cytochrome P450 system Drug safety and toxicology (including drug-drug interactions) And much more! Gain deep insights into GPCR drug candidates and learn the critical assays and techniques required to bring therapeutic molecules to life. 🚨 Only 25 spots available — register now! 💡 This is a great opportunity for both academia and industry professionals. Sessions will be live, and you’ll also have 1:1 discussion time with the instructor. Full PDFs of the slides will be available! 🔗 https://buff.ly/lVEcRUc #GPCR #DrugDevelopment #Pharmacokinetics #TherapeuticDrugs #OnlineCourse #DrGPCRUniversity #PharmaceuticalIndustry | Dr. GPCR Ecosystem
Gain deep insights into GPCR drug candidates and learn the critical assays and techniques required to Gain deep insights into GPCR drug candidates and learn the critical assays and techniques required to
- Revvity | Dr. GPCR Ecosystem
Discover pHSense™ portfolio From binding to signaling to internalization: Cell-based fluorescence assays This results in high sensitivity and specificity in no-wash, plate-based live-cell assays. pHSense™ Eu G-Protein Activation Quantify Gs, Gi, and Gq activation in real time with cAMP, GTP, and IP-One assays Arrestin Recruitment Detect β-arrestin recruitment with TR-FRET and luminescence assays tailored for Build Your GPCR Assay Workflow Meet the Team behind pHSense™ Eric TRINQUET Sr Director Life Sciences
- A Brief History of allosteric modulation with Dr. Arthur Christopoulos | Dr. GPCR Ecosystem
He also discussed the evolution of the field, from biochemical radioligand binding assays to cell-based functional assays, and the influence of Terry Kenakin and chemical programs on his later work. They discussed strategies for analyzing large compound screening data, emphasizing robust assays and Arthur recounted a 2004 visit to a pharma company using replicates in assays. conversation highlighted the importance of establishing the correct disease context, setting up appropriate assays
- Dr. Alix A. J. Rouault | Dr. GPCR Ecosystem
I then undertook my first project where I demonstrated that MRAP2 regulates the signaling of multiple MRAP2 regulates GHSR1a signaling; this project brought forth our NanoBiT-based arrestin recruitment assay This powerful tool allowed us to create an assay that kinetically measured the arrestin recruitment to I joined the lab, I became proficient in many In-vivo techniques, I adapted my arrestin recruitment assay
- Chemical Probes for GPCR Imaging and Internalization with Dr. Johannes Broichhagen | Dr. GPCR Ecosystem
Johannes Broichhagen reveals how fluorescent probes transform GPCR imaging, internalization studies, and assay He explains what chemical design can solve that antibodies can’t, how to validate functional assay systems , and why fluorescence-based assays paired with careful synthetic planning open doors for both high-resolution How parallel synthesis and side-by-side functional assays accelerate probe optimization and reduce false Tried to build assays that behave in living cells—not just on paper.
- Dr. Ralf Jockers | Dr. GPCR Ecosystem
INSERM with a specific interest in G protein-coupled receptors by developing original BRET and TR-FRET assays He discovered multiple rare and loss-of-function variants of the MT2 melatonin receptors that are associated
- Tanishka S. Saraf | Dr. GPCR Ecosystem
During my PhD, I learnt radioligand binding assays, behavioral assays, autoradiography, stereotaxic surgeries
- pharmacology at your fingertips terrys corner launches | Dr. GPCR Ecosystem
Whether you’re refining assay strategy or evaluating data, these lessons give you the tools to think Yamina’s Corner—GPCR consulting to de-risk and accelerate your pipeline ♦️ Celtarys’ validated TR-FRET assay
- From Pipettes to Platforms The Evolution of GPCR Research | Dr. GPCR Ecosystem
GPCR Podcast Back when GPCR assays were performed with single channel pipettes, failure wasn’t cheap. Michelle Halls still remembers pipetting one sample at a time, holding her breath to keep the assay alive
- Custom Molecules, Fluorescent Probes: When Chemists Think Like Biologists with Dr. Maria Majellaro from Celtarys | Dr. GPCR Ecosystem
Discover how Celtarys Research is transforming GPCR assay development with fluorescent ligands in this focus is on enabling fast, customizable development of fluorescent ligands and chemical probes for GPCR assays GPCR, Celtarys will bring those lessons to the broader community, providing insight into assay development Each probe must retain activity, remain soluble, and be compatible with a given assay format. Whether you're designing assays, developing probes, or seeking better tools for GPCR drug discovery,
- Flash News: Your Hub for GPCR Insights and Scientific Conference Programs
This is the kind of advance that matters for anyone building tools, assays, or therapeutics around receptor GPCR Podcast Read full article Back when GPCR assays were performed with single channel pipettes, failure Michelle Halls still remembers pipetting one sample at a time, holding her breath to keep the assay alive To stay relevant in the next decade, it’s not about chasing the latest assay or tool. receptor-ligand interactions after the fact; they aim to forecast receptor behavior before the first assay
- Scaling GLP 1 Receptor Tools Through Academia Industry Collaboration | Dr. GPCR Ecosystem
How academia and biotech collaborate to scale GPCR tools—covering fluorescence assays, GPCR internalization The episode explores gpcr internalization , fluorescence-based probe design, and how functional assay tools lose impact when distribution and access aren’t planned from the start Why fluorescence-based assays from academic tool development to real-world adoption Balancing innovation with validation in GPCR assay Her work centers on GPCR modulators, synthetic chemistry, and enabling robust biological assays through
- Dr. David Sykes | Dr. GPCR Ecosystem
David has over 20+ years of experience working in a drug discovery environment mainly in a specialist assay His current interests include the development of HTS fluorescence-based kinetic binding assays specifically
- Celtarys Research | Dr. GPCR Ecosystem
His focus is on expanding commercial reach and accelerating the adoption of the company’s GPCR assay from Celtarys Research Dec 9, 2025 5 min read High-Content Screening for GPCR Programs: Overcoming Assay interactions in intact cells offers advantages that extend far beyond traditional biochemical or radioligand assays fluorescently labeled ligands and innovative chemical biology tools to support real-time, non-radioactive GPCR assays GPCR Functional Assay Fluorescent GTPγS enables sensitive, non-radioactive GPCR activity assays for drug
















